Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared an article by Frank J. Lowery, et al. on X:
“Today!
TILs Tumor Infiltrating Lymphocytes – a cell-based therapy for patients with colorectal and GI cancers.
Responses plus “survivors” – black arrows. Four >48-month survival approximately CURES.
Pembro increases responses.
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
Authors: Frank J. Lowery, Stephanie L. Goff, Steven A. Rosenberg et al.
More posts featuring Pashtoon Kasi.
